Effects of Buteyko Breathing Exercise in Children With Uncontrolled Asthma

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-17
SponsorIvan Sofian Wibowo

About this trial

This randomized controlled trial study aimed to measure the effectiveness of the combination of 4-weeks Buteyko breathing exercises and pharmacological therapy compared with pharmacological therapy alone in children with uncontrolled asthma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children aged 7-17 years

Uncontrolled or partially controlled asthma (GINA Symptom Control Tool score > 1)

Receive bronchodilator therapy, either oral or inhaler from a pediatrician.

Children and parents/care givers agree to participate in the study until the end, and parents/care givers sign the informed consent form.

Disqualifiers

Inpatients

Have received Buteyko breathing exercises or other breathing exercises.

Have congenital heart disease, pneumonia, or other significant and uncontrolled health disorders.

Have severe physical disabilities or mental retardation that could potentially prevent the implementation of Buteyko breathing exercises.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Buteyko

    Behavioral

    The Buteyko breathing exercise is a method that encourages nasal breathing, reducing breathing volume, and using breath-holding exercises to normalize breathing pattern

  • Asthma reliever and controller

    Drug

    Asthma reliever and controller according to GINA (Global Initiative for Asthma) guideline

Treatment groups

74 Participants
are divided into 2 treatment groups
Group A: ButeykoExperimental treatment 2 interventions
Group B: ControlActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Asthma control

Level of asthma control measured by Asthma Control Questionnaire (ACQ) - Indonesian version. Minimum value 0, maximum value 6. Higher score means worse outcome.

Time frame
At enrollment and end of fourth-week

Secondary outcomes

1

Asthma Quality of Life

Measured by Pediatric Asthma Quality of Life Questionnaire standardized version (PAQLQ(S)) - Indonesian version. Minimum value 1, maximum value 7. Higher scores means better outcome.

Time frame
At enrollment and end of fourth-week
2

Bronchodilator use

Bronchodilator use measured by logbook, recorded by caregiver of patients

Time frame
At end of fourth-week
3

FEV1

Forced Expiratory Volume in one second reflects degree of airway obstruction. Measured by spirometry.

Time frame
At enrollment and end of fourth-week
4

FVC

Forced Vital Capacity is total volume of air that can forcefully exhale after taking the deepest possible breath. Measured by spirometry.

Time frame
At enrollment and end of fourth-week

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ivan Sofian Wibowo

Lead sponsor

Indonesia University

Sponsor institution

Fakultas Kedokteran Universitas Indonesia

Collaborator

Dr Cipto Mangunkusumo General Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: